"Clinical research in cardiology, diabetes, obesity and vascular medicine"

During the past decade, Core Research Group Pty Ltd conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 11 clinical trials were completed, i.e. on average, 45.8% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 7 clinical trials were completed. i.e. 38.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Core Research Group Pty Ltd" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Pfizer" with 4 trials sponsored, "Amgen" with 3 trials sponsored, "Bayer" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Core Research Group Pty Ltd" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Janssen Biotech, Inc." with 1 trials as a collaborator, "The Cleveland Clinic" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Core Research Group Pty Ltd" are "Cardiovascular Disease" (4 trials), "COVID-19" (3 trials), "Heart Failure" (3 trials), "Type 2 Diabetes" (3 trials) and "Obesity" (2 trials). Many other conditions were trialed in "Core Research Group Pty Ltd" in a lesser frequency.

Most popular intervention types in "Core Research Group Pty Ltd" are "Drug" (25 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Tirzepatide" (5 trials), "Empagliflozin" (2 trials), "Insulin Glargine" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Core Research Group Pty Ltd" are 28 trials for "All" genders.

Currently, there are NaN active trials in "Core Research Group Pty Ltd". undefined are not yet recruiting, 7 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Core Research Group Pty Ltd, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Core Research Group Pty Ltd, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".